Xueqing Yu

20.5k total citations · 3 hit papers
352 papers, 12.3k citations indexed

About

Xueqing Yu is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Xueqing Yu has authored 352 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Nephrology, 76 papers in Molecular Biology and 46 papers in Immunology. Recurrent topics in Xueqing Yu's work include Dialysis and Renal Disease Management (114 papers), Renal Diseases and Glomerulopathies (68 papers) and Chronic Kidney Disease and Diabetes (51 papers). Xueqing Yu is often cited by papers focused on Dialysis and Renal Disease Management (114 papers), Renal Diseases and Glomerulopathies (68 papers) and Chronic Kidney Disease and Diabetes (51 papers). Xueqing Yu collaborates with scholars based in China, United States and Hong Kong. Xueqing Yu's co-authors include Xiao Yang, Hui Y. Lan, Haiping Mao, Li Zuo, Guobin Xu, Jinjin Fan, Jinsheng Xu, Wen Huang, Songmin Huang and Yingchun Ma and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Xueqing Yu

342 papers receiving 12.1k citations

Hit Papers

Modified Glomerular Filtration Rate Estimating Equation f... 2006 2026 2012 2019 2006 2020 2022 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney Disease
    2006 1.6k citations Jianghua Chen, Xueqing Yu et al. profile →
  2. Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
    2020 549 citations Xueqing Yu et al. profile →
  3. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment
    2022 261 citations Philip Kam‐Tao Li, Kai Ming Chow et al. Peritoneal Dialysis International profile →

Peers

Xueqing Yu
Cheuk‐Chun Szeto Hong Kong
Günter Wolf Germany
Francesco Paolo Schena Italy
Xiangmei Chen China
Kar Neng Lai Hong Kong
Hitoshi Yokoyama Japan
Ichiei Narita Japan
Sydney Tang Hong Kong
Shin‐Wook Kang South Korea
Matthew J. Grainge United Kingdom
Cheuk‐Chun Szeto Hong Kong
Xueqing Yu
Citations per year, relative to Xueqing Yu Xueqing Yu (= 1×) peers Cheuk‐Chun Szeto

Countries citing papers authored by Xueqing Yu

Since Specialization
Citations

This map shows the geographic impact of Xueqing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Yu more than expected).

Fields of papers citing papers by Xueqing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Yu. The network helps show where Xueqing Yu may publish in the future.

Co-authorship network of co-authors of Xueqing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqing Yu. A scholar is included among the top collaborators of Xueqing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqing Yu. Xueqing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xueqing. (2025). Pioneering Multidisciplinary Innovation: A Year in Review and Vision for the Future. SHILAP Revista de lepidopterología. 3(1). 7–8. 2 indexed citations
2.
3.
Zhong, Yu, Biao Wei, Wenbiao Wang, et al.. (2024). Single-Cell RNA-Sequencing Identifies Bone Marrow-Derived Progenitor Cells as a Main Source of Extracellular Matrix-Producing Cells Across Multiple Organ-Based Fibrotic Diseases. International Journal of Biological Sciences. 20(13). 5027–5042. 7 indexed citations
4.
Zhu, Yan, et al.. (2024). The multilevel extensive diversity across the cynomolgus macaque captured by ultra-deep adaptive immune receptor repertoire sequencing. Science Advances. 10(4). eadj5640–eadj5640. 2 indexed citations
5.
Liang, Xinling, Jianteng Xie, Yanning Zhang, et al.. (2024). Enarodustat for the Treatment of Anemia in Chinese Patients with Non-Dialysis Chronic Kidney Disease: A Phase 3 Trial. SHILAP Revista de lepidopterología. 11(1). 49–62.
6.
Li, Philip Kam‐Tao, Jack Kit‐Chung Ng, Guangyan Cai, et al.. (2024). Navigating the Global Economic Landscape of Dialysis: A Summary of Expert Opinions from The 4th International Congress of Chinese Nephrologists. SHILAP Revista de lepidopterología. 10(5). 384–397. 1 indexed citations
7.
Qian, Junyan, Xinzhuang Yang, Jiuliang Zhao, et al.. (2023). Association Study Identified HLA‐DQA1 as a Novel Genetic Risk of Systemic Lupus Erythematosus‐Associated Pulmonary Arterial Hypertension. Arthritis & Rheumatology. 75(12). 2207–2215. 8 indexed citations
8.
Li, Philip Kam‐Tao, Kai Ming Chow, Yeoungjee Cho, et al.. (2022). ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Peritoneal Dialysis International. 42(2). 110–153. 261 indexed citations breakdown →
9.
Lian, Guang‐Yu, Yingpeng Wan, Qingming Wang, et al.. (2022). Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects. Biomaterials. 288. 121730–121730. 15 indexed citations
10.
Li, Philip Kam‐Tao, Wanhong Lu, Siu‐Ka Mak, et al.. (2022). Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology. 27(10). 787–794. 26 indexed citations
11.
Yu, Xueqing, Vivekanand Jha, & Hidetomo Nakamoto. (2022). Should More Patients with Kidney Failure Bring Treatment Home? What We Have Learned from COVID-19. SHILAP Revista de lepidopterología. 8(5). 357–367. 2 indexed citations
12.
Li, Jianbo, Naya Huang, Hongjian Ye, et al.. (2021). Prevalence, risk factors and impact on outcomes of 30-day unexpected rehospitalization in incident peritoneal dialysis patients. BMC Nephrology. 22(1). 4–4. 2 indexed citations
13.
Wu, Haishan, Chunyan Yi, Dihua Zhang, et al.. (2021). Changes of antibiotic resistance over time among Escherichia coli peritonitis in Southern China. Peritoneal Dialysis International. 42(2). 218–222. 7 indexed citations
14.
Li, Philip Kam‐Tao, Gordon Chun‐Kau Chan, Jianghua Chen, et al.. (2021). Tackling Dialysis Burden around the World: A Global Challenge. SHILAP Revista de lepidopterología. 7(3). 167–175. 28 indexed citations
15.
Ye, Hongjian, Chunyan Yi, Jianxiong Lin, et al.. (2020). Roles of peritoneal clearance and residual kidney removal in control of uric acid in patients on peritoneal dialysis. BMC Nephrology. 21(1). 4 indexed citations
16.
Fan, Jinjin, et al.. (2019). Roles of Inflammasomes in Inflammatory Kidney Diseases. Mediators of Inflammation. 2019. 1–14. 44 indexed citations
17.
Ye, Hongjian, Xiao Yang, Chunyan Yi, et al.. (2019). Urgent-start peritoneal dialysis for patients with end stage renal disease: a 10-year retrospective study. BMC Nephrology. 20(1). 238–238. 37 indexed citations
18.
Cai, Lu, Jianwen Yu, Yuan Peng, et al.. (2018). Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis. BMC Nephrology. 19(1). 297–297. 19 indexed citations
19.
Zhou, Yi, Huimei Chen, Xueqing Yu, et al.. (2017). Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice. The Journal of Immunology. 198(5). 1846–1854. 22 indexed citations
20.
Yi, Chunyan, Xiao Yang, Qunying Guo, et al.. (2011). Clinical features of the first episode of peritonitis in patients with long-term peritoneal dialysis. 27(10). 715–719. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheuk‐Chun Szeto Breakdown of academic impact, for papers by Günter Wolf Breakdown of academic impact, for papers by Francesco Paolo Schena Breakdown of academic impact, for papers by Xiangmei Chen Breakdown of academic impact, for papers by Kar Neng Lai Breakdown of academic impact, for papers by Hitoshi Yokoyama Breakdown of academic impact, for papers by Ichiei Narita Breakdown of academic impact, for papers by Sydney Tang Breakdown of academic impact, for papers by Shin‐Wook Kang Breakdown of academic impact, for papers by Matthew J. Grainge
Rankless by CCL
2026